Professional Product List 2015
|
|
- Berenice Young
- 8 years ago
- Views:
Transcription
1 Trade diagnostical products for clinical laboratories products for life. Professional Product List 2015 CLINICAL CHEMISTRY Occupational Medicine Drugs of Abuse TDM High Diagnostic Sensitivity and Specificity - Easily adaptable to most common automated Open Systems - Colour-Coded kit reagents for easy recognition - Economical Benefit - Controls and Calibrators included - 24 Month shelf life Test diagnostici in vitro ad alta specificità e sensibilità dedicati alla Medicina del Lavoro, monitoraggio farmaci e rilevazione Droghe d Abuso. Meridian Healthcare Professional Product List 2015 Occupational Medicine
2 1
3 Indice - Index PRODUCT NAME PAGE MEDICINA DEL LAVORO - OCCUPATIONAL MEDICINE 3 DROGHE D ABUSO - DRUGS of ABUSE TEST - DOA 4 MONITORAGGIO FARMACI - THERAPEUTIC DRUG MONITORING - TDM 5 CONTATTI - CUSTOMER SUPPORT 8 2
4 PRODUCT NAME REF PACKAGING OCCUPATIONAL MEDICINE AAP Urine - Colorimetric x6 ml ACE UV Liquid - Fixed Time x20 ml ALA Dehydrase - Colorimetric Tests ALCOHOL Ethanol Liquid - Enzymatic Endpoint UNIVERSAL x25 ml ALCOHOL Ethanol - Prestige 24i Packaging 36 tray x30 ml ALCOHOL Ethanol - Prestige 24i Packaging 24 tray x30 ml ALCOHOL Ethanol - Mindray BS200 Packaging x35 ml ALCOHOL Ethanol - Mindray BS300 Packaging x40 ml ALCOHOL Ethanol - Hitachi Packaging x40 ml ALCOHOL Ethanol - Olympus Packaging x32 ml AMMONIA - Enzymatic UV x2,5 Ml AMYLASE Pancreatic - Kinetic AD1009PE 4x25 + 4x5 ml CARBOXYHEMOGLOBIN - Enzymatic UV x5 ml CITRIC ACID - Enzymatic UV x20 ml HIPPURIC ACID - Colorimetric Test HYDROXYPROLINE - Colorimetric x3 Test LACTATE Liquid - Colorimetric x25 ml LYSOZYME - Turbidimetric x6 ml METHEMOGLOBIN - Spectrophotometric Test NAG - Colorimetric x4 ml PHENOLS - Colorimetric Test TRICHLORACETIC ACID - Colorimetric Test XYLOSE - Colorimetric Test G6-PDH Visual - Test qualitativo di screening per rilevare la carenza della Glucosio 6 Fosfato Deidrogenasi. Qualitative screening test for Glucose-6 Phosphate Dehydrogenase deficiency Test G6-PDH CareStart - Test qualitativo di screening per rilevare la carenza della Glucosio 6 Fosfato Deidrogenasi. Qualitative screening test for Glucose-6 Phosphate Dehydrogenase deficiency. G Card 3
5 PRODUCT NAME REF PACKAGING DRUGS OF ABUSE TEST - DOA BARBITURATES - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml BENZODIAZEPINE - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml COCAINE - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml COTININE- Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml ECSTASY - MDMA - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml EDDP - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml MARIHUANA - CANNABIS - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml METHADONE - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml MORPHINE - OPIATES - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml OXYCODONE - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml PHENCYCLIDINE - Quantitative UNIVERSAL KIT ADOA ml + 7,5 Ml PROPOXPHENE - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml 6-ACETYLMORPHINE - Quantitative UNIVERSAL KIT ADOA ml + 7,5 ml DOA-8 Test Cup (Split type) + 2 adulterant - Test rapido per la determinazione simultanea qualitativa di 8 droghe e loro metaboliti nell urina, inclusi due test di validità campione (S.V.T. ) AMP 500, BUP 10,COC 300, THC 50, MTD 300, MET 500, MDMA 500,MOP PH, Creatinine) Multi Drug Screen Panel is one-step panel immunoassay for the qualitative detection of multiple drug metabolites in human urine, collecting and Urine Check for the validation of Urine Specimen Examined. MULTI DRUG Panel 10 parametri - Test rapido per la determinazione simultanea qualitativa di 10 droghe e loro metaboliti nell urina umana. (AMP 500, BUP 10,COC 300, THC 50, MTD 300, MET 500, MDMA 500,MOP 300) Multi Drug Screen Panel is a lateral flow one-step panel immunoassay for the qualitative detection of multiple drug metabolites in human urine ALCOHOL TEST Saliva - Test rapido per la determinazione del tasso alcolemico su saliva. The ALCOHOL-Screen Saliva test can be used any time, any place. Each strip test is individually wrapped and completely disposable. Alcohol detection using a saliva sample can be more sensitive and accurate. ALCOHOL TEST Urina - Test rapido per la determinazione del tasso alcolemico su campioni di urina. The ALCOHOL-Screen Urine test can be used any time, any place. Each strip test is individually wrapped and completely disposable. Alcohol detection using a urine sample can be more sensitive and accurate. Detection Limit: 40 mg/dl ( 0,04 g/dl ) 1L26P3 1L26M3 1L29S5 1L29S3 10 Test 25 Card 25 Strip 50 Strip 4
6 PRODUCT NAME REF PACKAGING TDM-THERAPEUTIC DRUG MONITORING AMIKACIN - Quantitative UNIVERSAL KIT ADTD2116 2x15 ml + 2x5,5 ml CARBAMAZEPINE - Quantitative UNIVERSAL KIT ADTD2117 2x12 ml + 2x5 ml CARBAMAZEPINE - Biolis 24i Packaging 24 tray x19,5 ml + 2x6,5 ml CARBAMAZEPINE - Biolis 24i Packaging 36 tray x18,5 ml + 2x6 ml CARBAMAZEPINE - Hitachi Packaging x12 ml + 1x7 ml CARBAMAZEPINE - Mindray BS300 Packaging x14,5 ml + 1x8,5 ml CARBAMAZEPINE Mindray - BS400 Packaging x14,5 ml + 1x8,5 ml DIGOSSINA - Quantitative UNIVERSAL KIT ADTD2122 2x8 ml + 2x6 ml DIGOSSINA - Biolis 24i Packaging 24 tray x11,5 ml + 2x7,5 ml DIGOSSINA Biolis - 24i Packaging 36 tray x10 ml + 2x7 ml DIGOSSINA Hitachi Packaging x9 ml + 2x5,5 ml DIGOSSINA Mindray - BS300 Packaging x12,5 ml + 2x8,5 ml DIGOSSINA Mindray - BS400 Packaging x18 ml + 1x12,5 ml GENTAMICINA - Quantitative UNIVERSAL KIT ADTD2118 2x15 ml + 2x6 ml GENTAMICINA - Biolis 24i Packaging 24 tray x15 ml + 2x6 ml GENTAMICINA - Biolis 24i Packaging 36 tray x14 ml + 2x5,5 ml GENTAMICINA - Hitachi Packaging x14 ml + 1x8 ml GENTAMICINA - Mindray BS300 Packaging x14,5 ml + 1x9,5 ml GENTAMICINA - Mindray BS400 Packaging x14,5 ml + 1x9,5 Ml PHENOBARBITAL - Quantitative UNIVERSAL KIT ADTD2117 2x17 ml + 2x6 ml PHENOBARBITAL - Biolis 24i Packaging 24 tray x19 ml + 2x6,5 ml PHENOBARBITAL - Biolis 24i Packaging 36 tray x18 ml + 2x6 ml PHENOBARBITAL - Hitachi 911/912 Packaging x16 ml + 1x8,5 ml PHENOBARBITAL - Mindray BS300 Packaging x18 ml + 2x6 ml PHENOBARBITAL - Mindray BS400 Packaging x18 ml + 2x6 ml PHENYTOIN - Quantitative UNIVERSAL KIT ADTD2126 2x17 ml + 2x6 ml 5
7 THEOPHYLLINE - Quantitative UNIVERSAL KIT ADTD2125 2x17 ml + 2x5 ml THEOPHYLLINE - Biolis 24i Packaging 24 tray x19,5 ml + 2x5 ml THEOPHYLLINE - Biolis 24i Packaging 36 tray x23 ml + 2x5 ml THEOPHYLLINE - Hitachi Packaging x18 ml + 1x6 ml THEOPHYLLINE - Mindray BS300 Packaging x20 ml + 1x7,5 ml THEOPHYLLINE - Mindray BS400 Packaging x20 ml + 1x7,5 ml VALPROIC ACID - Quantitative UNIVERSAL KIT ADTD2124 2x12 ml + 2x5 ml TOBRAMYCIN - Quantitative UNIVERSAL KIT ADTD2119 2x15 ml + 2x5,5 ml VANCOMYCIN - Quantitative UNIVERSAL KIT ADTD2131 1x19 ml + 1x19 ml DIGITOXIN Biolis - 24i Packaging 24 tray x11,5 ml + 2x7 ml DIGITOXIN Biolis - 24i Packaging 36 tray x10 ml + 2x6,5 ml DIGITOXIN Hitachi Packaging x10 ml + 2x6 ml DIGITOXIN Mindray - BS300 Packaging x14,5 ml + 2x9 ml DIGITOXIN Mindray - BS400 Packaging x18 ml + 1x10,5 ml CONTROL & CALIBRATOR AMIKACIN - Calibrator ADTD9802 6x1 ml TDM - Therapeutic Drug Calibrator ADTD9805 6x3 ml TOBRAMYCIN - Calibrator ADTD9806 2x7,5 Ml VANCOMYCIN - Calibrator ADTD9804 6x1 ml TDM - Therapeutic Drug Control ADTD9109 2x5 ml 6
8 CERTIFICAZIONI Tutti i test presenti in questo catalogo sono certificati CE e soddisfanno tutte le disposizioni della direttiva 98/79/CE e successive modifiche ed integrazioni che la riguardano - salvo diversamente indicato. CE marking of In Vitro Diagnostic Medical Devices - IVDD (98/79/EC) According to the IVDD, in vitro diagnostic medical devices include: reagents, reagent products, calibration materials, control materials, kits, instruments, apparatus, equipment, and systems that are intended for use in the examination of specimens taken from the human body (tissue, blood, urine, etc.) to diagnose diseases, to monitor a person s state of health, or to monitor therapeutic procedures. 7
9 Italy Corporate Headquarter Meridian Healthcare Via G. Guglielmino, Tremestieri Etneo (Catania) Italy Tel: / Fax: Customer Service Meridian Healthcare Tel: / Fax: mail: info@meridianhealthcare.it marketing@meridianhealthcare.it Technical Support Engineering Department Meridian Healthcare Tel: Fax: mail: specialist@meridianhealthcare.it Sales and Orders Meridian Healthcare Tel: Fax: mail: ordini@meridianhealthcare.it amministrazione@meridianhealthcare
Professional Product List 2016
Trade diagnostical products for clinical laboratories products for life. Professional Product List 2016 CLINICAL CHEMISTRY Occupational Medicine Drugs of Abuse TDM High Diagnostic Sensitivity and Specificity
More informationCollection Instructions for ARUP Drug Screen Kit #49204
Collection Instructions for ARUP Drug Screen Kit #49204 Manufacturer Purpose of Kit / Reagent (tests) Kit / Reagent Contents (list components) Other Supplies Needed ARUP Laboratories For Point of Collection
More informationcobas c 311 analyzer
cobas c 311 analyzer cobas brand Roche Diagnostics introduces the cobas brand as the umbrella for products used to complete or expand the screening, diagnostic and monitoring applications of the professional
More informationCOBAS INTEGRA 400 plus
COBAS INTEGRA 400 plus COBAS INTEGRA 400 plus Advantages Real security of results with the COBAS INTEGRA clot detection system cobas c packs make reagent preparation a task of the past Workflow consolidation
More informationAppropriate Use of UDT to Improve Patient Care
Published on OpioidRisk (http://www.opioidrisk.com) Home > Urine Drug Testing Urine Drug Testing This guide provides: Download Entire Guide [1] Appropriate use of Urine Drug Testing (UDT) to improve patient
More informationAU 400 T H E V I S I B L E D I F F E R E N C E A N A L Y S E R S Y S T E M F O R C L I N I C A L C H E M I S T R Y
AU 400 T H E V I S I B L E D I F F E R E N C E A N A L Y S E R S Y S T E M F O R C L I N I C A L C H E M I S T R Y O U T S T A N D I N G E N G I N E E R I N G I N A C O M P A C T A N A L Y S E R 1 2 Refrigerated
More informationCentral Government Laboratory Department of Health and Environment
Central Government Laboratory Department of Health and Environment Overview who we are and what we do What is available and what is protocol for good science Sample collection Screening Tests Confirmation
More informationToxicology CPT Code Changes for 2016
Beginning January 1, 2016, CMS deleted all 2015 drug testing G codes and will continue to not recognize the AMA CPT codes for drug testing. CMS created three G codes for presumptive testing and four G
More informationHELPING YOUR BUSINESS DO MORE Webinar Series
HELPING YOUR BUSINESS DO MORE Webinar Series The Employers Council of Iowa, the Greater Des Moines Partnership, Kaplan University and Iowa Works bring you a series of educational webinars. These webinars
More informationThe CPT code for Human papillomavirus (HPV) has changed from 87621 to 87624. This code (87624) covers testing for HPV High Risk genotypes.
January 2015 2015 CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural Terminology (CPT) Coding Manual on an annual basis. For 2015, the AMA made several
More informationFREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze
FREQUENTLY ASKED QUESTIONS Oral Fluid Drug Testing with Oral-Eze BENEFITS AND PRICING Q: What benefits does Oral-Eze present? A: The Oral-Eze Oral Fluid Collector has a built-in indicator for determining
More informationDrug Testing Reference Tables for Drug Courts
Drug Testing Reference Tables for Drug Courts July, 2009 Page 1 TABLE I. Specimen Detection Period Advantages Disadvantages URINE SWEAT (patch) ORAL FLUID (saliva) Provides a profile of both current and
More informationPRODUCT REFERENCE GUIDE
PRODUCT REFERENCE GUIDE DRUGS OF ABUSE DAM-101 1000 ng/ml 50 DAM-U101 500 ng/ml 50 DAM-A101 300 ng/ml 50 DAM-111 1000 ng/ml 25 Tests/Canister AMP Amphetamine DAM-102 1000 ng/ml DAM-A102 300 ng/ml DAM-114
More informationC. The prospective employee must thoroughly read the LFCC Pre-Employment Drug
Pre-Employment Drug Screening Policy Policy No. 40001 Effective Date March 2006 Revision Date Revision No. Approved: John J. Ski Sygielski and President s Cabinet Date: March 2006 1.0 Purpose Substance
More informationHillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction
Hillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction Drug testing beyond the health care and criminal justice systems has
More informationPractical Aspects of Drug Testing in Human Hair
Practical Aspects of Drug Testing in Human Hair Laboratory Perspective James A. Bourland, Ph.D., DABFT FOR INTERNAL USE ONLY. NOT FOR PRINT OR DISTRIBUTION Overview of Collection Process FOR INTERNAL USE
More informationInteragency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)
Appendix D: Urine Drug Testing for Monitoring Opioid Therapy i. Monitoring opioid therapy with urine drug testing (UDT) ii. UDT algorithm for monitoring opioid therapy iii. UDT clinical vignettes iv. Frequently
More informationCUT-OFF CONCENTRATIONS FOR DRUGS OF ABUSE IN SALIVA FOR DUI, DWI OR OTHER DRIVING-RELATED CRIMES
CUT-OFF CONCENTRATIONS FOR DRUGS OF ABUSE IN SALIVA FOR DUI, DWI OR OTHER DRIVING-RELATED CRIMES Vina SPIEHLER 1, Dene BALDWIN 2, Christopher HAND 2 1 DABFT, Newport Beach, United States of America 2 Cozart
More informationUnderstanding Drug Screens & PharmCAS Drug Screening Program Overview. Suzi Arant, Senior Business Developer July 8, 2011
Understanding Drug Screens & PharmCAS Drug Screening Program Overview Suzi Arant, Senior Business Developer July 8, 2011 Presentation Overview Drug Screening in Healthcare Drug Screening Panels Drugs of
More informationPAYMENT POLICY STATEMENT
PAYMENT POLICY STATEMENT Original Effective Date Next Annual Review Date Last Review / Revision Date 01/01/2014 04/05/2017 04/05/2016 Policy Name Policy Number Drug Screening Tests PY-0020 Policy Type
More information3.1. The procedure shall be applicable to all University employees.
LINCOLN UNIVERSITY Procedure: Confirmatory Testing for Substance Abuse Procedure Number: HRM 113p Effective Date: October 2008 Revisions: Review Officer: Chief Human Resources Officer 1. Purpose 1.1. It
More informationDICHIARAZIONE DI CONFORMITA
DICHIARAZIONE DI CONFORMITA DECLARATION OF CONFORMITY Fabbricante: SCREEN Italia s.r.l., via Volumnia 40/B, 06135 Ponte San Giovanni (Perugia) Manufacturer: SCREEN Italia s.r.l., via Volumnia 40/B, 06135
More informationDRUG SCREENING POLICY AND PROCEDURES Effective August 31, 2015
DRUG SCREENING POLICY AND PROCEDURES Effective August 31, 2015 The signatory parties recognize that drug abuse is an illness that creates serious problems for workers, their families, the workplace and
More informationDRI Amphetamines Assay
s Assay For In Vitro Diagnostic Use 10014585 (3 x 18 ml) 0017 (100 ml Kit) 0018 (500 ml Kit) Intended Use The s assay is intended for the qualitative or semi-quantitative determination of amphetamine and
More informationThis is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics
This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics Welcome to Mayo Medical Laboratories Hot Topics. These presentations provide short discussion
More informationDrug Utilization Is On The Rise
Objectives Identify the clinical issues related to opioid prescribing for chronic pain indications Define the clinical needs and expectations of urine drug testing in pain management Address preanalytical
More informationCANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program
CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program Health Canada Regulations on Medical Devices Vancouver, B.C. October 29, 2007 Nancy
More informationWhat Does the Drug Test Tell Us
What Does the Drug Test Tell Us QUALITATIVE TOXICOLOGY TESTING for CLINICAL MANAGEMENT of the PATIENT Background The qualitative drug test is often referred to as the drug screen - a misnomer Testing performed
More information2013 Annual Toxicology Report
213 Annual Toxicology Report Department of Justice Forensic Science Division Toxicology Department 2679 Palmer Street Missoula, MT 5988 DOJTOX@mt.gov Personnel Phil Kinsey Scott Larson Scott Schlueter
More informationI.M.P.A.C.T. Revised. SUBSTANCE ABUSE TESTING POLICY Part I. PROCEDURE MANUAL Part II
I.M.P.A.C.T. Revised SUBSTANCE ABUSE TESTING POLICY Part I & PROCEDURE MANUAL Part II REVISED June 2011 Revised Substance Abuse Policy Part I Table of Contents I. Preface I. Statement of Policy.........
More informationDUI in Southern Ohio MATT 2006
DUI in Southern Ohio MATT 2006 Laureen J. Marinetti, M.S., Ph.D. Chief Toxicologist Montgomery County Coroner s s Office & Miami Valley Regional Crime Lab (MVRCL) Dayton, Ohio Region The MVRCL is a regional
More informationREACH AIR MEDICAL SERVICES SUBSTANCE ABUSE POLICY FOR APPLICANTS APPLYING FOR SAFETY-SENSITIVE POSITIONS
EFFECTIVE DATE: 06/01/2013 REACH AIR MEDICAL SERVICES SUBSTANCE ABUSE POLICY FOR APPLICANTS APPLYING FOR SAFETY-SENSITIVE POSITIONS (FOR TESTING TO BE CONDUCTED IN CALIFORNIA [excluding the City of San
More informationNumber: TBD EFFECTIVE DATE: JULY 31, 2000 PROCEDURE STATEMENT
Number: TBD EFFECTIVE DATE: JULY 31, 2000 PROCEDURE STATEMENT Policy Area: Supervision Issue: Drug Surveillance Action/Guidance: Chain-of-Custody Procedures Context: CSOSA conducts drug testing on all
More informationPennsylvania Hospital & Surgery Center ADMINISTRATIVE POLICY MANUAL
Page 1 Issued: May 2003 Committee Approval: Human Resources Administrative Policy Review Committee: May 2004 May 2005 May 2007 June 2008 Attachment(s): Consent Acknowledgement Form Related Policies: POLICY
More informationDRUG AND ALCOHOL TESTING REGULATIONS
DRUG AND ALCOHOL TESTING REGULATIONS Title 15: Mississippi State Department of Health Part 3: Office of Health Protection Subpart 1: Health Facilities Licensure and Certification Post Office Box 1700 Jackson,
More informationDrug Testing for Criminal Justice Involved Individuals in Michigan
Drug Testing for Criminal Justice Involved Individuals in Michigan Oakland County Drug Court Professionals Barbara M. Hankey, Manager Oakland County Community Corrections Session Goals O To present the
More informationGUIDELINES ON MEDICAL DEVICES. IVD GUIDANCES : Borderline issues A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single Market : regulatory environment, standardisation and New Approach Pressure equipment, medical devices, metrology MEDDEV. 2.14/1 rev. 1 January
More informationWhy do employers drug test? How is drug testing conducted and how accurate is it?
Workplace Drug Testing Drug testing is one action an employer can take to determine if employees or job applicants are using drugs. It can identify evidence of recent use of alcohol, prescription drugs
More informationAppropriate utilization of drug tests for pain management patients
Appropriate utilization of drug tests for pain management patients Gwen McMillin, PhD, DABCC (CC, TC) Medical Director, Toxicology, ARUP Laboratories Associate Professor (clinical), University of Utah
More informationI.M.P.A.C.T. National Drug Testing and Substance Abuse Program and Guidelines
IRONWORKER MANAGEMENT PROGRESSIVE ACTION COOPERATIVE TRUST I.M.P.A.C.T. National Drug Testing and Substance Abuse Program and Guidelines Effective The processes and procedures outlined may be used as a
More informationNALCOR ENERGY ALCOHOL AND DRUG PROGRAM REQUIREMENTS FOR CONTRACTORS
NALCOR ENERGY ALCOHOL AND DRUG PROGRAM REQUIREMENTS FOR CONTRACTORS At Nalcor Energy, safety is our top priority. We take collective pride in our commitment to ensuring employees, contractors and visitors
More informationClinical Drug Screening and/or Drug Testing
Manual: Policy Title: Reimbursement Policy Clinical Drug Screening and/or Drug Testing Section: Laboratory & Pathology Subsection: None Date of Origin: 10/26/2011 Policy Number: RPM016 Last Updated: 1/8/2016
More informationAlcohol, Drug and Mental Health Services Alcohol & Drug Program County of Santa Barbara DRUG TESTING POLICY & PROCEDURES
Effective December 2, 2013 Alcohol, Drug and Mental Health Services Alcohol & Drug Program County of Santa Barbara DRUG TESTING POLICY & PROCEDURES The policies and procedures set forth in this document
More informationUrine Drug Testing Methadone 101 Methadone for hospitalists
Urine Drug Testing Methadone 101 Methadone for hospitalists Dr. Patricia Mark MB, BCh LEARNING OBJECTIVES Clarify the purpose of urine drug testing Distinguish between UDT for detection of illicit drug
More informationDrug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
More informationPtProtect Pain Medication Management Program Monitors Patient Compliance
PHYSICIAN UPDATE 2013 Edition PtProtect Pain Medication Management Program Monitors Patient Compliance The PtProtect (Patient Protect) program offers pain medication management panels designed to improve
More informationPain Medication Management Program Monitors Patient Compliance
PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your
More informationThe Medical Laboratory Licensing Regulations, 1995
1 The Medical Laboratory Licensing Regulations, 1995 being Chapter M-9.2 Reg 1 (effective March 1, 1996) as amended by Saskatchewan Regulations 23/2004, 87/2007 and 88/2013. NOTE: This consolidation is
More informationJune 2016 Updated Crosswalk:
June 2016 Updated Crosswalk: 2016 HCPCS G0279 G6001 G6002 G6003 G6004 deleted f Radiology Coding BCBSNC currently considers this service investigational and will not cover either the HCPCS CPT s. Diagnostic
More informationHair Drug & Alcohol Testing FAQs
HAIR DRUG TESTING More than DNA Hair Drug & Alcohol Testing FAQs Need advice about testing? Contact us using our online SMS service or call Cellmark free on 0800 043 4247 2045 Introduction Cellmark is
More informationThe potential of oral fluid as a specimen in various drug testing programs
The potential of oral fluid as a specimen in various drug testing programs *Christine Moore, Cynthia Coulter, Katherine Crompton, Warren Rodrigues, Michael Vincent, James Soares Immunalysis Corporation,
More informationUpdate on Drug Impaired Driving. WTSC Impaired Driver Conference SeaTac, December 2006
Update on Drug Impaired Driving WTSC Impaired Driver Conference SeaTac, December 2006 12/4/2007 Alcohol, Drugs and Driving Household Survey, 2004 (prior year) Any Illicit Drug Use 19.9 Million 8.3% Marijuana
More informationAn Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse
Drug Testing An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Printed on August 18, 2016 1:59 pm CST 2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.
More informationTechnical Note. Introduction. Edward J. Cone. Lance Presley, Michael Lehrer, William Seiter, and Melissa Smith
Technical Note Oral Fluid Testing for Drugs of Abuse: Positive Prevalence Rates by Intercept Immunoassay Screening and GC MS MS Confirmation and Suggested Cutoff Concentrations * Edward J. Cone ConeChem
More informationMaking the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications
TECHNICAL NOTE Toxicology Making the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications Introduction The resolving power of chromatography combined with
More informationFS FSC. Abbreviations in common use. Fluid-stable, ready-to-use reagent. Fluid-stable concentrated reagent for measurement on Olympus AU systems
00_Dia_Umschl_ProductCat_281010 28.10.2010 16:25 Uhr Seite 1 C ::001 ::002 ::003 ::004 ::005 M Y CM MY ::006 CY CMY K ::007 ::008 ::009 ::010 ::011 ::012 ::013 ::014 ::015 ::016 ::017 ::018 11 2 ::019
More informationUNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION
UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION NUMBER: P 1.01 Page 1 of 1 PATIENT SAFETY SYSTEM/PSS:
More informationProfessional Product List 2015
Trade diagnostical products for clinical laboratories products for life. Professional Product List 2015 Rapid Tests Immunological Rapid Tests for Laboratory Diagnostics Lateral Flow ImmunoFlow Latex Kit
More informationHow To Test For Drugs And Alcohol
Group Policy GE Healthcare issued By. HUMAN RESOURCES NO 2.7 To be Reviewed: November 2013 Date 9/13/10 subject DRUG-FREE WORKPLACE I. INTRODUCTION GE Healthcare believes that its employees are the Company's
More informationTechnical Procedure for the Solid Phase Extraction of Acidic, Neutral and Basic Drugs for GC-MS Analysis
Technical Procedure for the Solid Phase Extraction of Acidic, Neutral and Basic Drugs for GC-MS Analysis 1.0 Purpose - This procedure specifies the required elements for the solid phase extraction of acidic,
More informationcat gue Human and animal care
cat alo gue INDEX Foreword 5 Urine Test Strips and Readers 6 Rapid Tests 6 p r e g n a n c y t e s t s 6 d r u g s o f a b u s e 6 o t h e r s 7 Rapid Latex Slide Tests 8 Coagulation 9 Turbidimetric Tests
More informationURINE DRUG TESTING. Effective December 1 st, 2012
URINE DRUG TESTING Effective December 1 st, 2012 Policy Neighborhood Health Plan (NHP) reimburses medically appropriate urine drug testing (UDT) to detect the parent drug and/or its metabolite(s) to demonstrate
More informationCreatine Kinase (CK) Enzymatic Assay Kit Manual Catalog #: 3460-07
Creatine Kinase (CK) Enzymatic Assay Kit Manual Catalog #: 3460-07 TABLE OF CONTENTS GENERAL INFORMATION... 2 Product Description... 2 Procedure Overview... 2 Kit Contents, Storage and Shelf Life... 3
More informationAdvantages & Disadvantages of Drug Testing in Alternative Matrices
Advantages & Disadvantages of Drug Testing in Alternative Matrices Marilyn A. Huestis, Ph.D. Chief, Chemistry & Drug Metabolism, IRP National Institute on Drug Abuse National Institutes of Health OJP Offender
More informationOral Fluid Testing: Promises and Pitfalls
Clinical Chemistry 57:6 805 810 (2011) Q&A Oral Fluid Testing: Promises and Pitfalls Moderator: Marilyn A. Huestis 1* Experts: Alain Verstraete, 2 Tai C. Kwong, 3 Jorg Morland, 4 Michael J. Vincent, 5
More informationSMF Awareness Seminar 2014
SMF Awareness Seminar 2014 Clinical Evaluation for In Vitro Diagnostic Medical Devices Dr Jiang Naxin Health Sciences Authority Medical Device Branch 1 In vitro diagnostic product means Definition of IVD
More informationBEST PRACTICES IN DRUG TESTING OF HEALTHCARE PROFESSIONALS
ENSURING COMPLIANCE: EXPLORING BEST PRACTICES IN DRUG TESTING OF HEALTHCARE PROFESSIONALS Martha E. Brown, MD Associate Medical Director, PRN and UF Associate Professor Addiction Medicine Division Disclosures
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement On Drug Testing as a Component of Addiction Treatment and Monitoring Programs and in other Clinical Settings [Note: ASAM also has a Public
More informationIn vitro diagnostic reagent, calibrator and control material stability
In vitro diagnostic reagent, calibrator and control material stability Pauline Armstrong Randox Laboratories, Ltd. Crumlin The stability of in vitro medical diagnostic devices whether they are reagents,
More informationUrine Specimen Dilution: Assessment and Policy Recommendations
Urine Specimen Dilution: Assessment and Policy Recommendations Dr. Leo Kadehjian uly 21, 2003 The following comments and recommendations are for informational use only. Consultation with program counsel
More informationSERVING GRANITE CITY, MITCHELL, AND PONTOON BEACH
2001 Delmar Avenue Granite City, IL 62040-6238 618-452-6238 smrld.org Tina Hubert Executive Director SERVING GRANITE CITY, MITCHELL, AND PONTOON BEACH SMRLD Drug and Alcohol Free Workplace Policy Purpose
More informationSubstance Abuse Prevention Program
Planning, Design and Construction 14528 S Outer Forty Suite 100 Chesterfield, MO 63017 (314) 628-3494 (314) 628-3715 Substance Abuse Prevention Program REFERENCES: In an effort to create a safe workplace,
More informationBeware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD
1 Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD Executive Summary: The presence of low urine creatinine at insurance testing is associated with increased
More information15.110 ALCOHOL AND DRUG TESTING OF DEPARTMENT PERSONNEL
15.110 ALCOHOL AND DRUG TESTING OF DEPARTMENT PERSONNEL Reference: Administrative Regulation #52 (06/07) Manual of Rules and Regulations: 1.01, 1.02, 2.26 A/B, 6.01, 6.02 A/B, 6.03, 6.04, 6.05, 11.03 Public
More informationRoom Temp: 8 Hr. Room Temp: 8Hr. Room Temp: ASAP. Refrigerated (2-8C): 3D. Room Temp: ASAP. Refrigerated (2-8C): 3D
Diabetes Chem Panel (Glu, Trig, Chol, HDL, LDL, Chol:HDL Ratio, AST, ALT, BUN, Creat, GFR, Na, K, Cl, CO2, Ca) ANMC Lab Test Requirements Updated 4/7/15 Key: Room Temp (20-25C), Refrigerated (2-8C), (-15
More informationClinical Drug Testing in Primary Care
Clinical Drug Testing in Primary Care Technical Assistance Publication Series TAP 32 Clinical Drug Testing in Primary Care TAP Technical Assistance Publication Series 32 U.S. DEPARTMENT OF HEALTH AND
More informationDepartment of Health and Human Services. No. 94 May 15, 2015. Part II
Vol. 80 Friday, No. 94 May 15, 2015 Part II Department of Health and Human Services Substance Abuse and Mental Health Services Administration Mandatory Guidelines for Federal Workplace Drug Testing Programs;
More informationMaking the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications
Making the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications Introduction The resolving power of chromatography combined with the sensitivity and selectivity
More informationBSI: An In Vitro Diagnostics Notified Body. A guide to the In Vitro Diagnostic Directive....making excellence a habit.
BSI: An In Vitro Diagnostics Notified Body A guide to the In Vitro Diagnostic Directive...making excellence a habit. A BSI guide to the In Vitro Diagnostic Directive Introduction In Vitro Diagnostics (IVD)
More informationPort Hedland Port Authority. Fitness for Duty Procedure Alcohol and Drugs PR HS014
Port Hedland Port Authority Fitness for Duty Procedure Alcohol and Drugs PR HS014 Alcohol and Drugs: PR HS014 Table of Contents 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. OBJECTIVE...
More informationUse of On-Site Testing for Drugs of Abuse
Clinical Chemistry 48:10 1639 1646 (2002) Review Use of On-Site Testing for Drugs of Abuse Stephen George * and Robin A. Braithwaite Background: There is currently a profusion of nearpatient testing devices
More informationDRUG DRIVING OFFENCES
DRUG DRIVING OFFENCES Taking drug can affect body and mind coordination that can significantly impair the ability to drive a motor vehicle. Road Traffic Ordinance (Cap 374) was amended in 2011 in order
More informationMEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code
MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code Initial Assessment And Intervention This Code Can Be Used Only Once A Year For First Appointment Medical Nutrition Therapy
More informationIMMUNOASSAY CONTROL - LEVEL 1 (IA CONTROL 1)
0843 IMMUNOASSAY CONTROL - LEVEL 1 (IA CONTROL 1) Cat. No. IA2638 / IA2633 Lot No. 978EC Size: 10 x 5 ml / 12 x 5 ml Expiry: 2013-10 INTENDED USE This product is intended for in vitro diagnostic use in
More informationDrug-Testing Program. Overview
Sunnyvale Independent School District DrugTesting and Rehabilitation Program 20132014 DrugTesting Program Overview The District requires drug testing of any student in grade 912 who chooses to participate
More informationOneStep Fecal Occult Blood RapiDip InstaTest. Cat # 13020-1
CORTEZ DIAGNOSTICS, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 USA Tel: (818) 591-3030 Fax: (818) 591-8383 E-mail: onestep@rapidtest.com Web site: www.rapidtest.com See external label
More informationEmployer Drug Testing Solutions
Employer Drug Testing Solutions A broad range of testing and collection options backed by a service-oriented culture that s committed to showing we re there when you need us. Choose drug testing to help
More informationRANDOM DRUG AND ALCOHOL TESTING OF STUDENTS PARTICIPATING IN COMPETITIVE ACTIVITIES
Administrative Rule RANDOM DRUG AND ALCOHOL TESTING OF STUDENTS PARTICIPATING IN COMPETITIVE ACTIVITIES Code JCDAE-R Issued 06/14 Testing Coordinator The athletic director will coordinate and supervise
More informationA Report on Marijuana and Prescription Drugs
Prescription Drug Misuse in America A Report on Marijuana and Prescription Drugs Table of Contents Summary 2 Prescription Drug Misuse is Prevalent 6 Marijuana: The Most Misused Drug 8 Recreational Marijuana
More informationSubpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing
Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing Subpart H - Guidelines - General By law, proficiency testing (PT) programs are evaluated initially for CMS
More informationGeneral. What is a laboratory test? What is a waived test?
General What is a laboratory test? What is a waived test? Laboratory tests are medical procedures that involve testing samples of blood, urine, or other tissues or substances from the body. Information
More information2.0 Rationale, Purpose and Scope... 5. 4.0 Definitions... 6. 5.0 General Principles... 7
Table of Contents Principles of IVD Medical Devices Classification 1.0 Introduction... 4 2.0 Rationale, Purpose and Scope... 5 2.1 Rationale... 5 2.2 Purpose... 5 2.3 Scope... 5 3.0 References... 5 4.0
More informationTHE DRUG AND ALCOHOL SCREENING PROGRAM
THE DRUG AND ALCOHOL SCREENING PROGRAM Revision 8- June 1 2014 Table of Contents Page Section 1 Introduction 3 Section 2 Commitment to Confidentiality 3 Section 3 Card Identification System 4 Section 4
More informationOne Source Toxicology Laboratory, 1213 Genoa Red Bluff, Pasadena, Texas 77504
Validation of Analysis of Amphetamines, Opiates, Phencyclidine, Cocaine, and Benzoylecgonine in Oral Fluids by Liquid Chromatography Tandem Mass Spectrometry Subbarao V. Kala*, Steve E. Harris, Tom D.
More informationHealth Safety Environmental Program SUBSTANCE ABUSE PREVENTION
Effective Date 06/01/2011 PROGRAM The policies and procedures of this substance abuse prevention program apply to all company operations. This program facilitates compliance with the Arkansas Drug Free
More informationJuly 1, 2015 VIA EMAIL
July 1, 2015 VIA EMAIL Marc Hartstein Director, Hospital and Ambulatory Policy Group Centers for Medicare and Medicaid Services 7500 Security Boulevard Mail Stop C4-01-26 Baltimore, MD 21244 Dear Marc:
More informationPRINCIPLE. REF 442635 (200 tests/cartridge) REF 476836 (400 tests/cartridge) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Creatine Kinase REF 442635 (200 tests/cartridge) REF 476836 (400 tests/cartridge) For In Vitro Diagnostic Use ANNUAL
More informationST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare
ST. VINCENT'S MEDICAL CENTER St. Vincent's Healthcare Medical Technology St. Vincent s Schools of Medical Science Throughout Northeast Florida and Southern Georgia, St. Vincent s HealthCare is well known
More informationGeneration Drug Free Workplace Policy for Contractor Personnel
Generation Drug Free Workplace Policy for Contractor Personnel Revision: 04 Date: 05-06-15 Submitted: Electronic approval pages are archived in CSR Portfolio. Contact K. Kemp for a copy. Reviewed: Reviewed:
More information